Original article
Amniocentesis or chorionic villus sampling for prenatal genetic testing: A decision analysis

https://doi.org/10.1016/0895-4356(91)90027-7Get rights and content

Abstract

We used decision analysis to examine the strategies of amniocentesis, chorionic villus sampling, and no prenatal testing for a pregnant woman who would be 35 years of age at the expected date of delivery. Probabilities were obtained from the obstetric and genetics literature, and utilities from previously published standard reference gambles and from responses of obstetric residents and students recorded on a linear rating scale. The expected utility of amniocentesis exceeded that of chorionic villus sampling by 0.1 utility units, and of no prenatal testing by 0.12 utility units. The decision was insensitive to clinically plausible values for the probabilities of spontaneous abortion after amniocentesis and chorionic villus sampling, the probabilities of abnormal and indeterminate chorionic villus sampling results, the probability of an abnormal amniocentesis result after an indeterminate chorionic villus sampling, the sensitivities and specificities of amniocentesis and chorionic villus sampling, and the probabilities of significant maternal morbidity after first- and second-trimester therapeutic abortion. Chorionic villus sampling was preferred to amniocentesis when the utility of a first-trimester therapeutic abortion exceeded that of a second-trimester abortion by 23.2 utility units, or when the anxiety “cost” of awaiting second-trimester amniocentesis results exceeded 0.1 utility unit.

We conclude that over a range of assumptions concerning the probabilities involved in the prenatal testing decision, amniocentesis was preferred to chorionic villus sampling. However, for a decision maker for whom a second-trimester therapeutic abortion would be significantly less acceptable than a first-trimester procedure, or for whom the anxiety of awaiting second-trimester chromosomal diagnosis might be an important consideration, chorionic villus sampling could become the procedure of choice.

References (77)

  • G.W. Torrance

    Utility approach to measuring health-related quality of life

    J Chron Dis

    (1987)
  • D. Cadman et al.

    Construction of social value or utility-based health indices: the usefulness of factorial experimental design plans

    J Chron Dis

    (1986)
  • G.W. Torrance

    Social preferences for health states: an empirical evaluation of three measurement techniques

    Socioecon Planning Sci

    (1976)
  • M.M. McGovern et al.

    Acceptability of chorionic villi sampling for prenatal diagnosis

    Am J Obstet Gynecol

    (1986)
  • E.B. Hook et al.

    Chromosomal abnormality rates at amniocentesis and in live born infants

    JAMA

    (1983)
  • Midtrimester amniocentesis for prenatal diagnosis: safety and accuracy

    JAMA

    (1976)
  • J.W. Spencer et al.

    A comparison of chorionic villi sampling and amniocentesis: acceptability of procedure and maternal attachment to pregnancy

    Obstet Gynecol

    (1988)
  • G.G. Rhoads et al.

    The safety and efficacy of chorionic villus sampling for early prenatal diagnosis

    N Engl J Med

    (1989)
  • D.F. Callen et al.

    Extra embryonic/fetal karyotypic discordance during diagnostic chorionic villus sampling

    Prenat Diagn

    (1988)
  • S.G. Pauker et al.

    Decision analysis

    N Engl J Med

    (1997)
  • J.P. Kassirer et al.

    Decision analysis: a progress report

    Ann Intern Med

    (1987)
  • E. Hakim-Elahi et al.

    Complications of first-trimester abortion: a report of 170,000 cases

    Obstet Gynecol

    (1990)
  • J.L. Simpson et al.

    Low fetal loss rates after ultrasound-proved viability in early pregnancy

    JAMA

    (1987)
  • R.D. Wilson et al.

    Spontaneous abortion and pregnancy outcome after normal first-trimester ultrasound examination

    Obstet Gynecol

    (1986)
  • K.A. Cashner et al.

    Spontaneous fetal loss after demonstration of a live fetus in the first trimester

    Obstet Gynecol

    (1987)
  • W.E. MacKenzie et al.

    Spontaneous abortion rate in ultrasonographically viable pregnancies

    Obstet Gynecol

    (1988)
  • D.T.Y. Liu et al.

    A prospective study of spontaneous miscarriage in ultrasonographically normal pregnancies and relevance to chorionic villus sampling

    Prenat Diagn

    (1987)
  • P.E. Polani et al.

    Sixteen years' experience in counseling, diagnosis and prenatal detection in one genetic centre: progress, results, and problems

    J Med Genet

    (1979)
  • A. Daniel et al.

    Prenatal diagnosis in 3000 women for chromosome, X-linked, and metabolic disorders

    Am J Med Genet

    (1982)
  • N.E. Simpson et al.

    Prenatal diagnosis of genetic disease in Canada: report of a collaborative study

    Can Med Assoc J

    (1976)
  • J. Philip et al.

    Fetal chromosome analysis: screening for chromosome disease?

    Prenat Diagn

    (1983)
  • N.J. Leschot et al.

    Risks of midtrimester amniocentesis: assessment in 3000 pregnancies

    Br J Obstet Gynecol

    (1985)
  • A.G.W. Hunter et al.

    Midtrimester genetic amniocentesis in Eastern Ontario: a review from 1970–1985

    J Med Genet

    (1987)
  • J.V. Dacus et al.

    Genetic amniocentesis: a twelve years' experience

    Am J Med Genet

    (1985)
  • E. Terzian et al.

    A survey of diagnostic amniocentesis in Oxford for 1974–1981

    Prenat Diagn

    (1985)
  • J.A. Squire et al.

    Prenatal diagnosis and outcome of pregnancy in 2036 women investigated by amniocentesis

    Hum Genet

    (1982)
  • M.S. Golbus et al.

    Prenatal genetic diagnosis in 3000 amniocenteses

    N Engl J Med

    (1979)
  • Cited by (44)

    • New developments in prenatal diagnosis of congenital adrenal hyperplasia

      2017, Journal of Steroid Biochemistry and Molecular Biology
    • The consequences of implementing non-invasive prenatal testing in Dutch national health care: A cost-effectiveness analysis

      2014, European Journal of Obstetrics and Gynecology and Reproductive Biology
      Citation Excerpt :

      As invasive prenatal diagnosis is the gold standard for clinical decision-making these tests were modelled to be 100% sensitive and specific. Iatrogenic miscarriage rate was calculated by combining the miscarriage rates of chorionic villus sampling (0.5%) and amniocentesis (0.3%) with their share in the total number of invasive diagnostic procedures, 30% and 70%, respectively [15,16]. Assumptions were made regarding test uptake after the introduction of NIPT in Dutch health care, based on studies evaluating women's expressed interest in NIPT [28,29] and recent publications on actual choices made following the implementation of NIPT in prenatal care [30,31].

    • Ethnic and socio-economic differences in uptake of prenatal diagnostic tests for Down's syndrome

      2010, European Journal of Obstetrics and Gynecology and Reproductive Biology
      Citation Excerpt :

      In the years 2000–2004, the period addressed in the present study, prenatal testing for Down's syndrome in The Netherlands consisted of reimbursed AMN and CVS. Both tests were offered to women aged 36 or above, because their age-related risk of carrying a child with Down's syndrome was considered sufficiently high to compensate for the risk of procedure-related fetal loss (0.3–0.8%) associated with invasive testing methods, such as AMN and CVS [12,13]. Non-invasive risk assessment tests, such as maternal serum screening and nuchal translucency measurement, were implemented in prenatal care after this study period.

    View all citing articles on Scopus
    View full text